Moderna Stock Looks Sick; Here's How To Take Advantage With OptionsInvestors Business Daily • 11/30/23
Moderna stock falls as mRNA patent called ‘invalid' by European Patent OfficeProactive Investors • 11/21/23
Moderna Nears Key Technical Level With Indications Of Reversal (Rating Upgrade)Seeking Alpha • 11/20/23
Is Moderna Stock A Sell After Its Sales Guidance Undercuts 2024 Expectations?Investors Business Daily • 11/15/23
Moderna to Host Second Environmental, Social and Governance (ESG) Investor Event on December 7th, 2023Accesswire • 11/14/23
Why this Dow stock went from worst in 2022 to first in 2023 — and 13 turnaround candidates for 2024Market Watch • 11/09/23
Moderna Highlights its Digital and AI Strategy and Progress at Second Digital Investor EventAccesswire • 11/08/23
Cathie Wood Just Bought This Struggling Stock After Its Billion-Dollar Quarterly Loss. Should You?The Motley Fool • 11/07/23